Synergy between the antinociceptive effects of morphine and NSAIDs
Author
dc.contributor.author
Miranda, H. F.
Author
dc.contributor.author
Silva, E.
Author
dc.contributor.author
Pinardi,
Admission date
dc.date.accessioned
2019-03-11T12:55:16Z
Available date
dc.date.available
2019-03-11T12:55:16Z
Publication date
dc.date.issued
2004
Cita de ítem
dc.identifier.citation
Canadian Journal of Physiology and Pharmacology, Volumen 82, Issue 5, 2018, Pages 331-338
Identifier
dc.identifier.issn
00084212
Identifier
dc.identifier.other
10.1139/y04-027
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/164498
Abstract
dc.description.abstract
The intraperitoneal administration of morphine, diclofenac, ketoprofen, meloxicam, metamizol, paracetamol and piroxicam induced dose-dependent antinociception in mice tested with the acetic acid writhing test. The isobolographic analysis of the simultaneous intraperitoneal administration of fractions of the ED50's of morphine with each nonsteroidal anti-inflammatory drug (NSAID) demonstrated the existence of a supra-additive interaction (synergy). The selective antagonist of μ-opioid receptors naltrexone partially reversed the supra-additive interactions to additive interactions; however, the combinations of morphine/metamizol and morphine/paracetamol were completely antagonized, resulting in subadditive interactions. The selective antagonist of δ-opioid receptors naltrindole failed to significantly attenuate the combinations of morphine with ketoprofen, meloxicam and piroxicam, but decreased the activity of the combinations of morphine with diclofenac, metamizol and paracetamol, trans